China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Total Liabilities
Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has total liabilities worth CN¥19.18 Billion CNY (≈ $2.81 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Total Liabilities Trend (1997–2024)
This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 000999 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thai Airways International Public Company Limited
BK:THAI
|
Thailand | ฿227.75 Billion |
|
Western Superconducting Tech Co Ltd
SHG:688122
|
China | CN¥7.07 Billion |
|
Rising Nonferrous Metals Share Co Ltd
SHG:600259
|
China | CN¥4.19 Billion |
|
Mianyang Fulin Precision Machining Co Ltd
SHE:300432
|
China | CN¥8.71 Billion |
|
The People's Insurance Company (Group) of China Limited
F:PIR
|
Germany | €1.61 Trillion |
|
RTL Group SA
XETRA:RRTL
|
Germany | €4.99 Billion |
|
MEG Energy Corp
TO:MEG
|
Canada | CA$2.22 Billion |
|
Hanwha
KO:000880
|
Korea | ₩237.85 Trillion |
Liability Composition Analysis (1997–2024)
This chart breaks down China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see China Resources Sanjiu Medical & Pharmac (000999) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2024)
The table below shows the annual total liabilities of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥14.83 Billion ≈ $2.17 Billion |
-6.68% |
| 2023-12-31 | CN¥15.89 Billion ≈ $2.32 Billion |
+65.67% |
| 2022-12-31 | CN¥9.59 Billion ≈ $1.40 Billion |
+11.57% |
| 2021-12-31 | CN¥8.60 Billion ≈ $1.26 Billion |
+8.10% |
| 2020-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
+10.10% |
| 2019-12-31 | CN¥7.22 Billion ≈ $1.06 Billion |
+5.25% |
| 2018-12-31 | CN¥6.86 Billion ≈ $1.00 Billion |
+13.02% |
| 2017-12-31 | CN¥6.07 Billion ≈ $888.35 Million |
+25.68% |
| 2016-12-31 | CN¥4.83 Billion ≈ $706.84 Million |
+11.17% |
| 2015-12-31 | CN¥4.35 Billion ≈ $635.83 Million |
+18.34% |
| 2014-12-31 | CN¥3.67 Billion ≈ $537.29 Million |
-5.40% |
| 2013-12-31 | CN¥3.88 Billion ≈ $567.98 Million |
+27.83% |
| 2012-12-31 | CN¥3.04 Billion ≈ $444.31 Million |
+10.47% |
| 2011-12-31 | CN¥2.75 Billion ≈ $402.19 Million |
+68.89% |
| 2010-12-31 | CN¥1.63 Billion ≈ $238.14 Million |
-3.13% |
| 2009-12-31 | CN¥1.68 Billion ≈ $245.83 Million |
+2.51% |
| 2008-12-31 | CN¥1.64 Billion ≈ $239.80 Million |
-66.49% |
| 2007-12-31 | CN¥4.89 Billion ≈ $715.55 Million |
+8.44% |
| 2006-12-31 | CN¥4.51 Billion ≈ $659.87 Million |
-3.04% |
| 2005-12-31 | CN¥4.65 Billion ≈ $680.58 Million |
-4.88% |
| 2004-12-31 | CN¥4.89 Billion ≈ $715.53 Million |
-6.01% |
| 2003-12-31 | CN¥5.20 Billion ≈ $761.28 Million |
+31.76% |
| 2002-12-31 | CN¥3.95 Billion ≈ $577.75 Million |
+8.26% |
| 2001-12-31 | CN¥3.65 Billion ≈ $533.65 Million |
+25.34% |
| 2000-12-31 | CN¥2.91 Billion ≈ $425.77 Million |
+214.23% |
| 1999-12-31 | CN¥925.96 Million ≈ $135.50 Million |
-3.51% |
| 1998-12-31 | CN¥959.69 Million ≈ $140.43 Million |
+6.96% |
| 1997-12-31 | CN¥897.21 Million ≈ $131.29 Million |
-- |
About China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more